SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,861 | -85.1% | 20,421 | -80.1% | 0.00% | -83.3% |
| Q2 2023 | $476,848 | -43.6% | 102,548 | -43.9% | 0.01% | -47.8% |
| Q1 2023 | $844,832 | -32.2% | 182,864 | +18.6% | 0.02% | -34.3% |
| Q4 2022 | $1,245,984 | +288.2% | 154,206 | +166.5% | 0.04% | +218.2% |
| Q3 2022 | $321,000 | +53.6% | 57,869 | +312.1% | 0.01% | -15.4% |
| Q4 2021 | $209,000 | -17.4% | 14,041 | -56.9% | 0.01% | -27.8% |
| Q2 2020 | $253,000 | +125.9% | 32,601 | +219.1% | 0.02% | +157.1% |
| Q4 2019 | $112,000 | – | 10,215 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |